Tortle is a leading medical device manufacturer that offers a range of products, including the Tortle Midliner, Tortle Transportle™, and the FDA-Cleared Tortle Air Lucky Elephant Corrective Beanie. Founded in 2012 by Dr. Jane Scott, a Pediatrician and published author, Tortle aims to prevent and eliminate Flat Head Syndrome and its associated medical problems, which affect 50% of all newborns in the United States. Their products are FDA-Cleared and pediatrician-designed, providing doctors, nurses, and parents with effective, easy-to-use tools to promote consistency of care and unparalleled benefits to babies. The company operates in the E-Commerce and Medical Devices industries.
Tortle's innovative approach and focus on addressing a prevalent medical issue in infants positions them as a promising investment opportunity. The commitment to providing high-quality care, backed by FDA clearance, enhances the company's credibility and potential for growth. As the market for infant care products continues to expand, Tortle's unique offerings cater to a significant and growing demand, making it an attractive prospect for venture capital firms seeking opportunities in the healthcare sector.